Neurocrine Biosciences (NBIX) PEG Ratio
Market Cap: $10.56B
Avg Volume: 1.57M
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
PEG Ratio Summary
- Neurocrine Biosciences's trailing twelve month (TTM) PEG ratio is -2.57.
- Neurocrine Biosciences's annual PEG ratio as of today is 1.22.
- Neurocrine Biosciences's quarterly PEG ratio is -1.70.
What is the PEG Ratio?
The PEG ratio (Price/Earnings to Growth ratio) is a valuation metric for determining the relative trade-off between the price of a stock, the earnings generated per share (EPS), and the company's expected growth. A lower PEG ratio suggests that a stock may be undervalued given its earnings performance and growth potential.
How is the PEG Ratio calculated?
The PEG ratio is calculated by dividing the P/E ratio by the annual EPS growth. The formula is:
PEG Ratio = (P/E Ratio) / (EPS Growth Rate)
This helps investors to determine a stock's value while considering the company's earnings growth.
Related Metrics
Other important metrics to assess Neurocrine Biosciences's financial health include:
- P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
- Annual: 40.15
- Quarterly: 33.23
- TTM: 31.40
- P/S Ratio (Price to Sales Ratio) - compares the company's stock price to its revenues:
- Annual: 5.82
- Quarterly: 21.83
- TTM: 4.48
- P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
- Annual: 5.29
- Quarterly: 5.29
- TTM: 4.14
- P/CF Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
- Annual: 23.02
- Quarterly: 56.51
- TTM: 18.00
These metrics provide insights into Neurocrine Biosciences's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
TTM PEG Ratio
-2.57
Annual PEG Ratio
1.22
Quarterly PEG Ratio
-1.70
Neurocrine Biosciences Historical PEG Ratio
Historical P/E Ratio
Historical P/S Ratio
Historical P/B Ratio
Historical P/CF Ratio
Neurocrine Biosciences Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | PEG Ratio | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|---|
| 2024 | 1.22 | 40.15 | 5.82 | 5.29 | 23.02 |
| 2023 | 0.87 | 51.55 | 6.82 | 5.77 | 33.02 |
| 2022 | 1.07 | 74.06 | 7.69 | 6.70 | 33.71 |
| 2021 | -1.15 | 89.92 | 7.11 | 5.86 | 31.41 |
| 2020 | 0.02 | 21.91 | 8.53 | 7.92 | 39.05 |
| 2019 | 3.25 | 266.19 | 12.50 | 15.46 | 64.77 |
| 2018 | -2.84 | 322.70 | 15.10 | 14.17 | 67.21 |
| 2017 | 78.07 | -47.90 | 42.24 | 18.35 | -72.37 |
| 2016 | -0.43 | -23.74 | 223.32 | 10.64 | -31.55 |
| 2015 | -1.81 | -53.75 | 241.79 | 11.26 | -125.80 |
| 2014 | -1.58 | -27.52 | 0.00 | 7.98 | -35.34 |
| 2013 | 0.01 | -13.54 | 213.73 | 5.18 | -21.07 |
| 2012 | -1.10 | 97.68 | 9.24 | 3.18 | -13.91 |
| 2011 | -0.02 | 12.48 | 6.06 | 7.81 | -688.69 |
| 2010 | 0.57 | -50.65 | 12.05 | 20.86 | 8.08 |
Related Metrics
Explore detailed financial metrics and analysis for NBIX.